NEWS
CFO departure at Mesoblast shocks surprised shareholders
MELBOURNE: Mesoblast’s chief financial officer Josh Munter will leave the business by the ... read more
Positive signs for Clinuvel stroke treatment candidate
MELBOURNE: Billion-dollar pharmaceuticals developer Clinuvel has reported good news from the very early ... read more